Form 4: Pacira BioSciences Director Acquires Stock Options and Restricted Stock Units
SEC Form 4 Filing
Director Mark Froimson reports acquisition of stock options and restricted stock units in Pacira BioSciences.
Summary
- On June 12, 2024, Mark Froimson, a director of Pacira BioSciences, Inc. [PCRX], reported transactions involving the company's securities.
- Froimson acquired 5,230 shares of common stock at $0 and disposed of 13,073 shares of common stock.
- He also acquired 12,179 stock options with an exercise price of $28.68, exercisable from June 12, 2025, to June 12, 2034.
- These stock options relate to 12,179 shares of common stock.
- Additionally, he acquired 5,230 restricted stock units, vesting on June 12, 2025, contingent upon continued service with Pacira BioSciences.
Sentiment
Score: 6
Explanation: The sentiment is neutral. While the director acquired stock options and restricted stock units, indicating confidence, they also disposed of some shares. The overall impact is likely minimal.
Positives
- The acquisition of stock options and restricted stock units by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Negatives
- The disposal of 13,073 shares of common stock by the director could be interpreted negatively, although the acquisition of restricted stock units and options may offset this concern.
Risks
- The value of the stock options is dependent on the future performance of Pacira BioSciences' stock.
- The restricted stock units are subject to vesting requirements, meaning the director must remain with the company to realize their value.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are closely monitored by investors for insights into management's perspective on the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how investors interpret the director's actions.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: acquisition of common stock, stock options, and restricted stock units; disposal of common stock. |
| 06/12/2025 | Vesting date for restricted stock units. |
| 06/12/2034 | Expiration date for stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.